THEBUSINESSBYTES
BUREAU
BHUBANESWAR,
OCTOBER 1, 2026
The growing role of
genomic medicine in cancer care, rare disease diagnosis and personalised
treatment came under the spotlight at a scientific meeting in Bhubaneswar, with
medical experts underscoring the need to make advanced molecular diagnostics
more accessible to patients in Odisha. The scientific evening on “Advances in
Genomic Medicine”, organised by 3D Genomix Healthcare, brought together senior
oncologists, hematologists, pathologists, academicians and healthcare
professionals to discuss developments in genomic testing and its integration
into clinical practice.
The initiative comes
at a time when advances in molecular diagnostics are increasingly enabling
doctors to obtain detailed information about the genetic and molecular
characteristics of diseases, potentially supporting more individualised
approaches to diagnosis, treatment and monitoring.
3D Genomix Healthcare
was founded by Dr Aditya Samal, Dr Nityanada Upadhyay, Dr Arun Mohanty and
Sribatsha Rath with the objective of improving access to advanced molecular
diagnostics and genomic medicine in Odisha and across Eastern India.
In his welcome
address, Dr Arun Mohanty, CEO of 3D Genomix Healthcare, outlined the
organisation’s vision and highlighted its key areas of work, including rare
genetic disorder evaluation, personalised oncogenomics, non-invasive cancer
monitoring, chimerism monitoring, pharmacogenomics and metagenomic diagnostics
for infectious diseases.
For Odisha, one of
the key objectives is to strengthen access to specialised genomic testing
within the state and reduce dependence on laboratories located outside the
region. The organisation plans to combine genomic technologies, bioinformatics,
AI-assisted interpretation and expert review to provide clinicians with
clinically relevant molecular information.
Such information can
be used, where appropriate, to support earlier diagnostic evaluation,
personalised treatment decisions, disease monitoring and family-based genetic
assessment.
The scientific
programme was moderated by Dr Chinmaya Pani, Medical Oncologist, Utkal
Hospital, and featured experts from leading institutions in India and the
United States.
Dr Rajyalakshmi
Luthra, Professor and Director, Molecular Diagnostics Laboratory, The
University of Texas MD Anderson Cancer Center, Houston, delivered the first
session on “Current Landscape of Genomic Testing in Patients with Solid
Tumors”.
The session focused
on the evolving role of genomic testing in solid tumours and the importance of
molecular information in contemporary cancer care.
The second scientific
session was delivered by Dr Sunil Jaiman, Assistant Professor, Department of
Pathology, Wayne State University School of Medicine, Detroit. He spoke on
“Perinatal Pathology in the Genomic Era”, highlighting the intersection of
genomic advances and perinatal pathology.
The presentations
were followed by an interactive discussion involving the speakers, senior
medical professionals and the audience. The deliberations focused on the
practical aspects of integrating genomic testing into clinical care in Odisha
and the challenges and opportunities associated with the adoption of advanced
molecular diagnostics.
The meeting also
brought together senior professionals from leading medical institutions in the
State, providing a platform for clinicians to exchange views on the emerging
applications of genomic medicine across different specialties.
With genomic
technologies evolving rapidly, the discussions highlighted the importance of
closer collaboration between clinicians, molecular diagnostic specialists,
pathologists and genomic medicine experts to translate advances in laboratory
science into meaningful clinical applications.
The programme concluded with a vote of thanks by Dr Sanjib Kumar Mishra, Director and Senior Consultant, Radiation Oncology, Utkal Hospital, Bhubaneswar.
The event was co-sponsored by Shanti Charitable Trust, Chennai.
